Option Care Health, Inc. (NASDAQ:OPCH) Shares Sold by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. decreased its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 25.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 21,377 shares of the company’s stock after selling 7,463 shares during the period. PNC Financial Services Group Inc.’s holdings in Option Care Health were worth $747,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Lindenwold Advisors INC acquired a new position in Option Care Health during the 1st quarter worth approximately $308,000. US Bancorp DE increased its position in Option Care Health by 5.0% during the 1st quarter. US Bancorp DE now owns 8,199 shares of the company’s stock worth $287,000 after purchasing an additional 393 shares during the period. Wealthquest Corp acquired a new position in Option Care Health during the 1st quarter worth approximately $66,000. Natixis Advisors LLC increased its position in Option Care Health by 33.8% during the 1st quarter. Natixis Advisors LLC now owns 50,654 shares of the company’s stock worth $1,770,000 after purchasing an additional 12,802 shares during the period. Finally, XTX Topco Ltd increased its position in Option Care Health by 27.4% during the 1st quarter. XTX Topco Ltd now owns 38,062 shares of the company’s stock worth $1,330,000 after purchasing an additional 8,177 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Price Performance

Shares of NASDAQ:OPCH opened at $27.85 on Tuesday. The business’s 50 day simple moving average is $30.56 and its 200-day simple moving average is $31.93. The firm has a market capitalization of $4.52 billion, a price-to-earnings ratio of 22.28, a price-to-earnings-growth ratio of 1.78 and a beta of 0.79. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53.

Option Care Health (NASDAQ:OPCH) last posted its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%. The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same quarter in the prior year, the company earned $0.30 EPS. Option Care Health’s revenue was up 15.4% on a year-over-year basis. As a group, equities analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

OPCH has been the topic of several recent analyst reports. JMP Securities boosted their target price on Option Care Health from $36.00 to $38.00 and gave the stock a “market outperform” rating in a research report on Thursday, July 31st. Citigroup reissued an “outperform” rating on shares of Option Care Health in a research note on Thursday, July 31st. Barrington Research reissued an “outperform” rating and set a $38.00 price target on shares of Option Care Health in a research note on Thursday, July 10th. Finally, UBS Group raised Option Care Health from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. One research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Option Care Health has an average rating of “Moderate Buy” and an average target price of $35.75.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.